4 reports

Major players in the clinical oncology next-generation sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences. The global clinical oncology next generation sequencing...

  • Cancer
  • DNA Sequencing
  • World
  • APAC
  • Cancer Incidence
  • Cancer Mortality

Major players in the clinical oncology next generation sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences. The global clinical oncology next generation sequencing...

  • Diagnostics
  • Public Health
  • Genome Sequencing
  • Drug Development
  • DNA Sequencing
  • Telecommuting
  • Breast Cancer
  • Cell Therapy
  • Industrial Automation
  • Oncology
  • World
  • APAC
  • Cancer Incidence
  • Cancer Mortality

INTRODUCTION Over the years, technological advances in the field of genomics have enabled pharma companies to adopt a more personalized and targeted approach to drug / therapy development. Specifically, next-generation sequencing (NGS) technologies have enabled millions of human genomes across diverse ethnicities, to be...

  • Genomics
  • Pharmaceutical
  • DNA Sequencing
  • World
  • APAC
  • North America
  • Europe

Global DNA Methylation Market to Reach $8.88 Billion by 2030 Market Report Coverage - DNA Methylation Market Segmentation • By Product: Consumables, Instruments, and Software • By Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, and others. • By Application: Clinical...

  • DNA Sequencing
  • World